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Few, if any, studies have examined the effect of vitamin E deficiency on brain mitochondrial oxidative phosphorylation. The latter was
studied using brain mitochondria isolated from control and vitamin E-deficient rats (13 months of deficiency) after exposure to iron, an
inducer of oxidative stress. Mitochondria were treated with iron (2 to 50 AM) added as ferrous ammonium sulfate. Rates of state 3 and state 4
respiration, respiratory control ratios, and ADP/O ratios were not affected by vitamin E deficiency alone. However, iron uncoupled oxidative
phosphorylation in vitamin E-deficient mitochondria, but not in controls. In vitamin E-deficient mitochondria, iron decreased ADP/O ratios
and markedly stimulated state 4 respiration; iron had only a modest effect on these parameters in control mitochondria. Thus, vitamin E may
have an important role in sustaining oxidative phosphorylation. Low concentrations of iron (2 to 5 AM) oxidized mitochondrial tocopherol
that exists in two pools. The release of iron in brain may impair oxidative phosphorylation, which would be exacerbated by vitamin E
deficiency. The results are important for understanding the pathogenesis of human brain disorders known to be associated with abnormalities
in mitochondrial function as well as iron homeostasis (e.g., Parkinson’s disease).
D 2004 Elsevier B.V. All rights reserved.Keywords: Vitamin E; Iron; Tocopherol; Mitochondria; Uncoupling; Deficiency1. Introduction
Vitamin E is the main chain-breaking antioxidant in
most, if not all, biological membranes. Therefore, it is not
surprising that a deficiency of vitamin E (mainly alpha-
tocopherol in animal experiments) results in a number of
pathological manifestations such as reproductive failure in
both male and female rats, liver necrosis in rats and pigs,
erythrocyte hemolysis, anemia, exudative diathesis, ence-0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2003.12.013
Abbreviations: RCR, respiratory control ratio (ratio of state 3 to state 4
respiration of mitochondria); State 3, rate of in vitro respiration (oxygen
consumption) of mitochondria upon stimulation with ADP (active or
stimulated respiration); State 4, rate of in vitro respiration (oxygen
consumption) of mitochondria under basal conditions (basal or controlled
respiration)
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E-mail address: vatas001@tc.umn.edu (G.T. Vatassery).phalomalacia, kidney degeneration, and nutritional muscular
dystrophy in different species of animals [1]. Even though a
deficiency of this nutrient seems to affect a number of
systems, it is likely that alpha-tocopherol plays a critical
role in the functioning of specific subcellular organelles or
enzymatic systems. One possibility is that the antioxidant
and/or another biological activity of alpha-tocopherol is
especially important for maintenance of mitochondrial func-
tion. Corwin [2] reviewed some of the early observations on
the effect of vitamin E deficiency on mitochondria and
noted that skeletal muscle from vitamin E-deficient animals
showed enhanced respiration whereas liver slices were
characterized by a decline in respiration. Schwarz [3] found
that liver homogenates from vitamin E-deficient rats could
not maintain normal oxygen consumption upon in vitro
incubation for a period of time. This phenomenon was
termed respiratory decline and could be prevented by
administration of alpha-tocopherol. However, as pointed
out by Corwin [2], the defective respiration (respiratory
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nates had been incubated in vitro for a few hours suggesting
that this may be a secondary effect. Since sulfhydryl groups
were lost during respiratory decline, the suggestion was that
alpha-tocopherol may be protecting critical enzyme sulfhy-
dryl groups [2]. In addition, morphological alterations in the
mitochondria from gracile and cuneate nuclei were reported
by Schochet [4] a number of years ago. Vitamin E-deficient
mitochondria were enlarged and pleomorphic; they under-
went a characteristic non-autophagic dissolution leading to
accumulation of masses of granular dense material.
Several investigations have examined the role of alpha-
tocopherol as an antioxidant in the mitochondrial mem-
branes. The interaction between the antioxidant activities of
ubiquinol and alpha-tocopherol in mitochondrial mem-
branes has been the subject of several studies. Ernster et
al. [5] observed that ubiquinol acted as a powerful antiox-
idant in submitochondrial particles from which tocopherol
had been extracted by treatment with pentane. However,
Kagan et al. [6] proposed that the antioxidant activity of
ubiquinol is mediated by its ability to regenerate alpha-
tocopherol from the alpha tocopheroxyl radical [7,8].
Maguire et al. [9] demonstrated that tocopheroxyl radical
can be reduced back to tocopherol by the respiratory chain.
They showed that NADH, succinate and reduced cyto-
chrome c linked oxidation were able to prevent the accu-
mulation of tocopheroxyl radical and the consumption of
alpha-tocopherol. In short, these reports suggest that the
oxidative consumption of alpha-tocopherol is controlled in a
complex manner by various factors including the levels of
reduced ubiquinone and the level of reduction of the
respiratory chain.
Few reports address the changes in tissue mitochondrial
oxygen consumption in vitamin E deficiency. For example,
Paraidathathu et al. [10] found that mitochondria from the
hearts of vitamin E-deficient and normal rats showed
similar respiratory control ratios (the ratio between oxygen
consumption under basal and ADP-induced conditions i.e.,
state 4 and 3 rates). This is in contrast to the work of
Ferrari et al. [11] who found that heart mitochondria from
rabbits fed a vitamin E-deficient diet had lower RCR than
control mitochondria. Thus, there are conflicting data on
the effects of vitamin E deficiency upon mitochondrial
oxygen consumption even among the limited number of
publications in the literature. Furthermore, brain mitochon-
dria were not studied in any of these investigations. Since
brain is a critical target of abnormal vitamin E status in
animals and man (see reviews by Vatassery et al. [12,13]),
it is important to understand the effect of vitamin E
deficiency upon brain mitochondria and this is one of the
goals of this report.
Oxidative stress can be induced in mitochondrial mem-
branes by a number of agents including metal ions such as
iron. Furthermore, abnormalities in iron metabolism have
been reported in many human brain disorders such as
Alzheimer’s disease, Parkinson’s disease and multiple scle-rosis (see review by Connor and Benkovic [14]). The
molecular mechanisms and proteins involved in processing
iron in cells have been studied extensively (see reviews by
Hill [15] and Eisenstein [16]). Among the many proteins
involved with iron metabolism, frataxin is of special inter-
est. It is a mitochondrial protein taking part in iron homeo-
stasis in the mitochondria and abnormal levels of this
protein is considered to be one of the major causes of
pathology in Friedrich’s ataxia [17]. In fact, Rustin et al.
[18] have considered Friedrich’s ataxia to be the most
common human mitochondrial disorder with mitochondrial
overloading of iron accompanied by deficiency of aconitase
and reduced respiration. It is noteworthy that Friedrich’s
ataxia is clinically very similar to inherited ataxia with
vitamin E deficiency [19]. In order to understand the
influence of antioxidants and iron in the pathogenesis of
disorders such as Friedrich’s ataxia and Alzheimer’s disease,
we need to understand more fully the influence of iron upon
mitochondrial metabolism. Little, if any, information is
available on the influence of iron on parameters of mito-
chondrial function such as respiration under vitamin E-
deficient conditions. Therefore, we have investigated the
effect of iron on the function of brain mitochondria from
control and vitamin E-deficient animals.2. Materials and methods
2.1. Chemicals
The chemicals used were of reagent grade purity from
standard sources. Solvents for chromatography were HPLC
grade from Burdick and Jackson Laboratories, Inc., Mus-
kegon, MI, USA. Other special chemicals were purchased
from the following sources: a-tocopherol and a-tocopher-
olquinone from Kodak Laboratory Chemicals, Rochester,
NY, USA; Ficoll (Type 400) from Sigma Chemicals, St.
Louis, MO, USA. Absolute ethanol was obtained from
Midwest Solvents Company, Pekin, IL, USA and was
redistilled prior to use. Most of the other reagent grade
chemicals including tris-ADP (equine muscle), L-glutamic
acid and L-malic acid were from Sigma.
2.2. Treatment of animals
All procedures with animals were approved by the
Subcommittee on Animal Studies of the Minneapolis Vet-
erans Affairs Medical Center. Male Fischer 344 rats were
obtained at weanling. These animals were placed on control
or vitamin E-deficient diet for a period of 13 months. The
diets were custom manufactured by Dyets Inc., Bethlehem,
PA 18017 (catalog numbers 119614 and 119615) according
to the specifications of AIN 93 purified diets for laboratory
rodents [20] and slightly modified for production of vitamin
E-deficient formulations. The lipid source was tocopherol-
stripped lard (10%). The control diet was obtained by the
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per kilogram of diet.
The animals were sacrificed by decapitation and the
cerebral hemispheres were quickly dissected out of two ani-
mals; the tissues were pooled and rapidly rinsed using
isotonic saline buffer. These samples were used for isolation
of mitochondria as described below.
2.3. Preparation of mitochondria
The subcellular fractions were isolated from cerebral
hemispheres by standard centrifugation methods [21]. The
Ficoll solution used was purified by dialyzing a 40% (w/v)
aqueous solution against nanopure (Millipore system) water
for 3 h. The final Ficoll concentration was estimated by
using a graph relating density and concentration. Using a
glass-glass homogenizer, rat brain hemisphere tissue was
homogenized in 10 volumes of ice-cold isolation medium
containing 0.3 M sucrose, 5 mM HEPES, 5 mM KH2PO4, 1
mM EGTA and 0.1% (w/v) fatty acid-free bovine serum
albumin adjusted to pH 7.4 with KOH. The homogenate
was centrifuged at 1300g for 3 min and the supernatant
saved. The pellet was resuspended in 10 ml of the isolation
medium, rehomogenized and centrifuged at 1300g for 3
min. The pooled supernatants were centrifuged at 17,000g
for 10 min to get the crude mitochondrial fraction. The
resulting pellet was resuspended in 8 ml of isolation
medium. This suspension was layered over 11 ml of 7.5%
(w/v) Ficoll medium which had been layered over 11 ml of
10% (w/v) Ficoll medium. The tubes were centrifuged in a
Beckman SW 28 rotor at 99,000g for 45 min. The
mitochondria that sedimented at the bottom were removed,
diluted 1:5 with isolation medium and centrifuged for 10
min at 17,000g. The mitochondria were washed once with
isolation medium. The purity of mitochondria was checked
by assaying for the marker enzyme succinate dehydrogenase
[22], which was enriched eight- to tenfold in the mitochon-
dria compared with crude homogenate.
2.4. Studies of mitochondrial respiration and sampling for
assays of alpha-tocopherol
Mitochondrial respiration was followed using the biolog-
ical oxygen monitor (Model 5300, YSI Company, Yellow
Springs, OH, USA). The system had a Clark electrode and a
microcell with a capacity of 0.6 ml. The mitochondria were
added to buffer (isolation medium without bovine serum
albumin and with only 50 AM EGTA) with substrate (10
mM glutamate and 2.5 mM malate or 5 mM succinate) in
the cell kept at 28–29 jC at a final protein concentration of
400 Ag/ml. Oxygen consumption was followed for 5 min
prior to the addition of ADP. Whenever ferrous iron sol-
utions were added, the mitochondria were incubated for 3
min in the presence of iron. The oxygen consumption was
traced on a strip chart recorder and the state 3 and state 4
respiratory rates were determined. The respiratory controlratios (state 3 rate/state 4 rate) (RCR) were also calculated.
Whenever iron was added, there is a slight increase in
oxygen consumption probably due to lipid peroxidation.
However, stable state 4 levels were established after the
equilibration time. The rate of phosphorylation was calcu-
lated in nanomoles of ADP phosphorylated per minute per
milligram of mitochondrial protein. After two cycles of
ADP-induced respiration, the mitochondria were removed
and stored for assays of alpha-tocopherol.
2.5. Determination of tocopherol
The method for determination of tocopherols by liquid
chromatography has been published [23]. Briefly, 2-ml
ethanol containing 0.025% (w/v) butylated hydroxytoluene
(BHT) and 0.1 ml of 30% (w/v) ascorbic acid were pipetted
into tubes containing samples for tocopherol analyses. The
mixture was saponified at 60 jC for 30 min after the
addition of 1 ml of 10% potassium hydroxide solution.
Tubes were cooled and 2 ml of water was added followed by
2 ml of hexane containing 0.025% (w/v) BHT. Tocopherols
and quinone were extracted into the hexane phase by
vortexing the samples for one minute. The hexane phase
was separated out and evaporated down under a stream of
nitrogen. The residue was redissolved in mobile phase and
analyzed by reverse phase liquid chromatography using the
following conditions: column=ultrasphere ODS, 5 Am,
4.6150 mm (Beckman Instruments, Fullerton, CA,
USA); mobile phase=methanol/water, (94.5:5.5) with 7.5
mM sodium dihydrogen phosphate (final concentration);
flow rate=2.7 ml/min. The tocopherols were detected elec-
trochemically: Coulochem 5100 A detector, 5011 analytical
cell with detector 1 at -0.25 V and detector 2 at +0.55 V and
5021 conditioning cell at 0.75 V.
2.6. Biochemical assays
Concentration of total protein was determined by the
Lowry technique as modified by Markwell et al. [24].3. Results
Alpha-tocopherol (the form of vitamin E present in
animal diets) was depleted more rapidly in peripheral tissues
such as serum and liver than in brain when rats were fed
vitamin E-deficient diets, in agreement with our early report
[25]. A comparison of the alpha-tocopherol levels in select-
ed tissues from control and vitamin E-deficient rats is shown
in Fig. 1. Alpha-tocopherol in the peripheral tissues of
vitamin E-deficient animals were barely detectable (less
than 1% of those from controls). The concentration of
alpha-tocopherol in brain of vitamin E-deficient rats was
reduced to 3–5% of control levels. Thus, it is important to
note that brain tissue from these vitamin E-deficient animals
cannot be considered to be free of alpha-tocopherol.
Fig. 1. Comparison of alpha-tocopherol concentrations in the brain and
peripheral tissues of rats raised on control or vitamin E-deficient diets. Male
Fisher 344 rats were raised on the respective diets for 13 months, the tissues
isolated and analyzed for alpha-tocopherol by HPLC.
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determined for brain mitochondria isolated from control and
vitamin E-deficient rats before and after the addition of
several different concentrations of iron. Mitochondrial res-
piration supported by glutamate/malate was determined
using a Clark electrode under basal conditions (state 4)
and after addition of 208.5 nmoles of ADP (state 3 respi-
ration). Different concentrations of iron in the form of
ferrous ammonium sulfate were added to the reaction
mixture before the measurement of oxygen consumption.
The respiratory control ratios (RCR) (ratio of state 3 to state
4 respiration) for mitochondria from control and vitamin E-Fig. 2. The respiratory control ratios (RCR) for brain mitochondria from
control and vitamin E-deficient rats. Male Fisher 344 rats were raised on
control and vitamin E-deficient diets for 13 months. The cerebral hemi-
spheres were dissected out, mitochondria isolated and incubated in 300 mM
sucrose, 5 mM HEPES, 5 mM KH2PO4 and 50 AM EGTA. The oxygen
consumption was determined under state 4 conditions with glutamate (10
mM)/malate (2.5 mM) as substrates and also under state 3 conditions after
the addition of 208.5 nmol of ADP. The ratios between state 3 and state 4
respiration rates were calculated as RCR.deficient rats were calculated. The results are shown in Fig.
2. Treatment of mitochondria with iron resulted in a loss of
respiratory control as seen by declining respiratory control
ratios with increasing concentrations of iron. Hence, the
presence of iron is deleterious to mitochondria from both
control and vitamin E-deficient brains. However, the vita-
min E-deficient mitochondria were more susceptible to iron
than control mitochondria. At an iron concentration of 50
AM, mitochondria from vitamin E-deficient brain showed a
total loss of respiratory control, i.e., the rates of state 3 and
state 4 respiration were the same.
The respiratory control ratios are composite indices of
mitochondrial function and are a ratio of state 3 (ADP-
stimulated) to state 4 (basal) respiration rates. Fig. 3A shows
the changes in rates of state 3 and state 4 respiration of brain
mitochondria from control rats after treatment with iron. A
significant decrease in state 3 and a modest increase in state
4 rates occurred upon treatment of the control mitochondriaFig. 3. Respiratory rates under state 3 and state 4 conditions of mito-
chondria from rat brains after exposure to different concentrations of iron:
(A) control and (B) vitamin E-deficient. The rate of respiration on the
ordinate is in arbitrary units: 1 unit=2.71 ng atoms oxygen. See legend of
Fig. 2 for details of experimental conditions.
Fig. 4. Rates of phosphorylation and ADP/O ratios of mitochondria from
rats after exposure to different concentrations of iron: (A) controls and (B)
vitamin E-deficient. The rate of phosphorylation is in nanomoles of ADP
phosphorylated per minute per milligram of mitochondrial protein. See
legend of Fig. 2 for experimental details.
Fig. 5. Changes in alpha-tocopherol concentrations of mitochondria from
brains of control and vitamin E-deficient rats. Mitochondria were isolated
from the cerebral hemispheres of control and vitamin E-deficient rats. They
were then suspended in buffer and placed in Clark electrode cell. After
study of respiration, the mitochondria were recovered and the alpha-
tocopherol concentrations determined by HPLC.
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induced a small increase in state 3 and a substantial increase
in state 4 respiration in vitamin E-deficient mitochondria as
shown in Fig. 3B.
The rates of phosphorylation and ADP/O ratios were also
calculated using the data from the above experiment and are
shown in Fig. 4A (control) and B (vitamin E-deficient).
Treatment of mitochondria from control animals with vary-
ing concentrations of iron resulted in a progressive decline
in phosphorylation rates and a lesser decline in ADP/O
ratios (Fig. 4A). Vitamin E-deficient mitochondria under-
went much more remarkable declines in both rates of
phosphorylation and ADP/O ratios compared with control
mitochondria (Fig. 4A and B). At 50 AM iron, the ADP/O
ratio for control mitochondria was still >2, whereas the
ADP/O ratio for vitamin E-deficient mitochondria was zero.
These data show that iron treatment results in minimal
uncoupling of oxidative phosphorylation in control mito-
chondria, while causing complete uncoupling in vitamin E-
deficient mitochondria.The effects of iron upon these mitochondrial functions
were also studied using succinate as substrate (data not
shown). The data were similar to those described above with
glutamate/malate as substrates. Again, iron inhibited state 3
respiration in control mitochondria, but not in vitamin E-
deficient mitochondria and iron markedly increased state 4
respiration in vitamin E-deficient mitochondria with a much
smaller increase observed with control mitochondria. Treat-
ment with iron decreased ADP/O ratios in vitamin E-
deficient, but not in control mitochondria.
We also examined whether treatment with iron resulted
in any changes in the alpha-tocopherol content of the brain
mitochondria under conditions identical to those used in
oxygen consumption studies. After two cycles of basal and
ADP-stimulated respiration, samples of mitochondria were
removed from the Clark electrode cell and assayed for
alpha-tocopherol as well as its oxidation product, tocopher-
olquinone, by HPLC. The results are shown in Fig. 5.
Alpha-tocopherol is lost from the mitochondria upon incu-
bation with iron at concentrations as low as 2.5 AM (Fig. 5).
Even the extremely small amount of alpha-tocopherol
present in the mitochondria from vitamin E-deficient diet
was lost after treatment with low concentrations of iron.
Thus, the vitamin E-deficient, iron-treated mitochondria
could be considered free of alpha-tocopherol. This may
contribute to the uncoupling of vitamin E-deficient mito-
chondria by iron. Note that vitamin E deficiency alone did
not result in uncoupling or alterations in RCR, rates of state
3 and 4 respiration, rate of phosphorylation or ADP/O
ratios. The changes in these parameters were observed only
after the vitamin E-deficient mitochondria were exposed to
iron in the medium.
The production of tocopherolquinone, the oxidation
product of tocopherol, was also monitored in the same
Fig. 6. Concentrations of tocopherolquinone in mitochondria treated with
iron. See legend of Fig. 5 for experimental details.
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since the quinone levels in vitamin E-deficient mitochondria
treated with iron were too low to quantify. The results in
Fig. 6 show a steady increase in the production of tocopher-
olquinone until the concentration of iron reached 25 AM, at
which point the tocopherolquinone production reached a
limiting level. Only a small fraction of alpha-tocopherol lost
was converted into its quinone with most of the remainder
being converted to other compounds that have not been
characterized. The data in Figs. 5 and 6 demonstrate that
oxidative stress was induced by incubating mitochondria
with iron and that a major portion of alpha-tocopherol was
consumed during this process.4. Discussion
Mitochondria are the major sites of utilization of cellular
iron and, hence, this subcellular organelle is likely to
encounter the most traffic in iron in various forms. A pool
of iron that has been referred to as the ‘‘intermediate or
chelatable iron’’ has been described by many investigators
and some suggest that almost 20% of the intracellular iron
may be in this compartment with mitochondria reported to
contain 40% of its iron content in this form [26,27]. The
range of the non-chelated (redox-active) pool of mitochon-
drial iron is reported to be about 12.2 AM in rat hepatocytes
[28]. This level falls within the range of iron concentrations
used in this investigation.
During this study, we have determined RCR, state 3 and
state 4 rates, ADP/O ratios and rates of phosphorylation
using mitochondria from vitamin E-deficient and control
animals before the addition of iron (see the initial data points
at zero concentrations of iron in Figs. 2–4). Invariably, we
found that vitamin E deficiency per se did not alter the
different respiratory properties of mitochondria. This obser-
vation agrees with that of Paraidathathu et al. [10] usingheart mitochondria from rats. Hence, a deficiency of vitamin
E per se does not seem to alter oxidative phosphorylation of
brain mitochondria. It is possible that the animals on the
long-term vitamin E-deficient diets could have developed
compensatory mechanisms to overcome the effects of lack
of alpha-tocopherol upon mitochondrial metabolism.
Our results demonstrate that substantial amounts of
mitochondrial alpha-tocopherol are consumed upon expo-
sure to low concentrations of iron. Examination of data for
control mitochondria shows that mitochondrial alpha-to-
copherol is quite sensitive to the presence of iron in the
medium (Fig. 5). In fact, the decline in alpha-tocopherol
induced by low concentrations of iron (2 to 5 AM) can be
used as a sensitive indicator of iron-induced oxidative stress
in mitochondria (Fig. 5). The levels of alpha-tocopherol
within the mitochondria in the controls go down to a
limiting level when the iron concentration in the medium
is 25 AM or more. This suggests the existence of two
different compartments (one labile and the other more
stable) of alpha-tocopherol within brain mitochondria. We
have observed similar results when brain subcellular frac-
tions were exposed to the synthetic free radical generator
2,2V-azobis(2-amidinopropane) dihydrochloride (ABAPH)
[29]. Melhorn et al. [30] have also found that when rat liver
microsomes and mitochondria were oxidized by enzymati-
cally generated free radicals, a portion of the tocopherol
remained unoxidized. One could speculate that the labile
compartment is functionally more important even though
we do not know the location and the conditions of utiliza-
tion of the different pools of tocopherol.
In vivo investigations involving ingestion of iron by
vitamin E-deficient animals have been reported by a couple
of groups. In one study, Bacon et al. [31] found that when
vitamin E-deficient rats were given chronic oral doses of
iron, there was a reduction in RCR in isolated liver
mitochondria. This experiment can be considered to be an
in vivo counterpart of our studies even though the source of
the mitochondria was the liver whereas we used brain
mitochondria. Results of Bacon et al. [31] agree with our
in vitro data showing that iron causes reductions in RCR
when the mitochondria are exposed to the metal. Link et al.
[32] examined the effect of vitamin E upon iron-induced
changes in mitochondria using iron-loaded heart cells from
the rat and found that the iron-loaded cells had substantially
reduced activities of complex I plus III as well as succinate
dehydrogenase. They found that alpha-tocopherol complete-
ly protected the damage to the mitochondrial enzymes
induced by iron loading without altering the uptake or
release of iron. Thus, the above studies show that alpha-
tocopherol and iron exhibit strong functional interactions in
mitochondria. Our data clearly demonstrate that the inter-
action between alpha-tocopherol and iron will modulate the
function of brain mitochondria.
We have shown that addition of iron leads to uncou-
pling of mitochondrial oxidative phosphorylation in vita-
min E deficiency. When vitamin E-deficient mitochondria
G.T. Vatassery et al. / Biochimica et Biophysica Acta 1688 (2004) 265–273 271were treated with increasing concentrations of iron, the
state 4 respiration rate was increased substantially (Fig.
3B). It is known that the rate of state 4 respiration is
controlled by proton leak across the mitochondrial inner
membrane [33]. Hence, vitamin E deficiency caused alter-
ations in mitochondrial membranes such that the rate of
proton leak is increased upon treatment with iron. Various
factors including alterations in the biochemical composi-
tion and architecture of the membranes can alter proton
leak. For example, Brand et al. [34] have shown that
proton leak is strikingly correlated with the fatty acid
composition of the membrane phospholipids. It is possible
that the vitamin E-deficient membranes were more peroxi-
dized upon treatment with iron and this resulted in a
change in proton leak.
The susceptibility of the vitamin E-deficient mitochon-
dria to iron-induced stress was observed whether glutamate/
malate or succinate was used as substrates. Succinate-
supported respiration has been shown to be more susceptible
to production of reaction oxygen species [35] and one
would have expected the vitamin E-deficient brain mito-
chondria to be more susceptible to damage from exposure to
iron when succinate was used as a substrate. This was not
the case. Hence, it is possible that alpha-tocopherol may
have other functions in mitochondria in addition to being a
powerful membrane lipid antioxidant as has been suggested
by some studies [36].Fig. 7. A hypothetical scheme of the mechanism of induction ofThe exact molecular mechanism of how iron uncouples
vitamin E-deficient mitochondria is unknown. We have
formulated a hypothetical scheme, which is shown in Fig.
7. The addition of iron to vitamin E-deficient mitochondria
will be expected to initiate oxidative chain reactions in the
membrane. Critical components will be oxidized resulting
in excessive production of superoxide by the respiratory
chain. This sequence of events is supported by studies of
Cornejo et al. [37] who showed that submitochondrial
particles from the liver of iron-overloaded rats produce
significantly more superoxide than controls. Superoxide
formed can activate uncoupling protein(s) and induce
uncoupling as reported by Echtay et al. [38] from the
Brand group. In addition, superoxide can also inhibit
dehydratases such as aconitase [39] and cause abnormal-
ities in oxidative metabolism which in turn can result in
uncoupling. Finally, studies of Putvinsky et al. [40] have
established more than two decades ago that lipid perox-
idation can induce increases in electrical conductance; this
can also cause uncoupling. The changes in uncoupling
protein activity, generation of lipid peroxidation products,
alterations in enzyme activity or increased electrical con-
ductance could all be ultimately responsible for increased
proton leak leading to uncoupling. Vitamin E is a very
potent, lipid-soluble antioxidant ideally located within the
membranes preventing most of these changes under normal
physiological conditions.mitochondrial uncoupling by iron in vitamin E deficiency.
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iron results in uncoupling of oxidative phosphorylation of
vitamin E-deficient mitochondria. The concentrations of
iron used were within the range of the non-chelated (re-
dox-active) pool of mitochondrial iron, which is reported to
be about 12.2 AM in rat hepatocytes [28]. The results
suggest that alpha-tocopherol may have a specific role in
maintaining oxidative phosphorylation especially under ox-
idative stress induced by iron. It can be postulated that
alpha-tocopherol may have a role in modulating mitochon-
drial proton leak. Whenever there is an imbalance in cellular
iron homeostasis, the antioxidant status of mitochondria
(especially with respect to vitamin E) needs to be carefully
considered when assessing iron toxicity. Thus, our findings
would be particularly relevant for understanding the patho-
physiological mechanisms involved in neurodegenerative
disorders such as Alzheimer’s and Parkinson’s diseases
and Friedrich’s ataxia where abnormal iron metabolism
and/or oxidative stress has been demonstrated to be present.Acknowledgements
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